The Claim
In adults with mild type 2 diabetes, a 12-week ketogenic diet is associated with a 32% reduction in palmitoleic acid levels compared to a low-fat diet, and this reduction indicates suppression of de novo lipogenesis in the liver.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with mild type 2 diabetes, following a ketogenic diet for 12 weeks results in a 32% lower level of palmitoleic acid compared to a low-fat diet, which reflects reduced production of new fat molecules by the liver.
See the scientific wording
In adults with mild type 2 diabetes, a 12-week ketogenic diet is associated with a 32% reduction in palmitoleic acid, a biomarker of de novo lipogenesis, compared to a low-fat diet, indicating that carbohydrate restriction suppresses the liver's production of new fat molecules.
When carbs are very low, the liver makes less sugar from food, so it has less fuel to build new fat. Instead, the liver breaks down fat into ketones for energy. This happens because the drop in sugar lowers insulin and raises glucagon, which turns off the enzyme that starts fat production and turns on the pathway that burns fat. The fat-building marker palmitoleic acid drops because the liver stops making new fat and starts burning it instead.
What the research says
1 studyPeople with mild type 2 diabetes who ate very few carbs for 12 weeks had 32% less of a fat-making marker in their blood than those on a low-fat diet, meaning their livers made less new fat.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.